Wednesday
SESSION 31: ADVANCES IN MEDICAL TREATMENTS, NEW ANTI-ATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
Location: Grand Ballroom West, 3rd Floor
Moderators:Peter Henke, MD / Ido Weinberg, MD, MSc  
SESSION 31 SCHEDULE
6:46 AM - 6:51 AM

Power Point Presentation with Synched Audio
New Information From The VOYAGER And COMPASS Trials With Rivaroxaban (Xarelto From Janssen And J&J) And Aspirin: How Does It Help In The Management Of Patients With Arterial And Venous Disease: With And Without Kidney Disease And With And Without Statins
  Presenter(s):Marianne Brodmann, MD  
Location: Grand Ballroom West, 3rd Floor
6:52 AM - 6:57 AM New Strategies On How To Avoid And Treat Perioperative Myocardial Infarctions (MIs) In Open Vascular Surgery Patients
  Presenter(s):Peter Henke, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
6:58 AM - 7:03 AM

Power Point Presentation with Synched Audio
Update On LDL-C Lowering During A Lifetime: How Low To Strive For With Intensive Drug Therapy: How Young To Start If High; How Old To Continue Statins
  Presenter(s):J. David Spence, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:04 AM - 7:09 AM DEBATE: LDL-C Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful: What Does The Latest Evidence Show
  Presenter(s):Sherif A.H. Sultan, MD, PhD, FRCS, EBQS-VASC, FACS  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:10 AM - 7:15 AM DEBATE: Not So: Update On LDL-C Lowering With Statins And Other Drugs Stabilizes And Shrinks Plaques And Decreases Morbid Vascular Events: Stopping Statins Increases Patientsí Risk Of MI And Death
  Presenter(s):Ron Waksman, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:16 AM - 7:21 AM Low Dose Rivaroxaban (Xarelto From Janssen And J&J) And Aspirin Improve Survival And Decrease Major Adverse Limb Events (MALE) After Endo And Open Treatments For PAD/CLTI: From The VOYAGER RCT: What Does The XATOA Prospective Registry Add
  Presenter(s):Sebastian E. Debus, MD, PhD / Marianne Brodmann, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:22 AM - 7:27 AM

Power Point Presentation with Synched Audio
How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And COMPASS Trials
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:28 AM - 7:33 AM New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimbe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:34 AM - 7:42 AM Panel Discussion
END OF SESSION 31
previous next